References
1. P. K. Leprosy, “Text Book of Preventive and Social Me- dicine,” 19th Edition, M/S Banarasi Das bhanot, Jabalpur, pp. 264-278. World Health Organization, “Global Burden of Leprosy at the End of 2010,” The Weekly Epidemiological Record, Vol. 86, 2011, pp. 389-40
2. Leena Das, Bijay Kumar Meher, Nikunja Bihari Das, Deepti Damayanty Pradhan, S. Pradeep, Jayashree Mohanty A Clinco-Bacteriological Study of Leprosy in Paediatric Age Group Advances in Infectious Diseases, 2013, 3, 269-273
3. MD Anderson News Release 02/20/2014 ,Research at The University of Texas MD Anderson Cancer Center
4. Singh P, Cole ST. Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future microbiology. 2011;6(1): 57-71. doi:10.2217/fmb.10.153.
5. S. T. Cole, K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Massive gene decay in the leprosy bacillus Nature 409, 1007-1011 (22 February 2001) doi:10.1038/35059006;
6. Amanda Nogueira Brum Fontes, Rama Murthy Sakamuri, Ida Maria Foschiani Dias Baptista, Somei Ura, Milton Ozo´ Rio Moraes, Alejandra No´ Brega Marti´Nez, Euzenir Nunes Sarno, Patrick J. Brennan, Varalakshmi D. Vissa & Philip noel suffys Genetic diversity of Mycobacterium leprae isolates from Brazilian leprosy patients Lepr Rev (2009) 80, 302–315
7. Sunil Dogra, Tarun Narang & Bhushan Kumar. Leprosy - evolution of the path to eradication Indian J Med Res 137, January 2013, pp 15-35
8. Caroline A. Nelson, Carrie Kovarik & christiaan B. Morssinky: A literature review of applications of telemedicine and tele-education to leprosy Lepr Rev (2014) 85, 250–261n
9. Idema WJ, Majer IM, Pahan D, Oskam L, Polinder S, Richardus JH. Cost-Effectiveness of a Chemoprophylactic Intervention with Single Dose Rifampicin in Contacts of New Leprosy Patients. Carabin H, ed. PLoS Neglected Tropical Diseases. 2010;4(11):e874. doi:10.1371/journal.pntd.0000874.
10. W. Cairns S. Smith & Ann Aerts Role of contact tracing and prevention strategies in the interruption of leprosy transmission Lepr Rev (2014) 85, 2–17
11. WHO’sEnhanced Global Strategy for Further Reducing the Disease Burden due to Leprosy (PlanPeriod: 2011–2015)
12. Lastória JC, de Abreu MAMM. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1 . Anais Brasileiros de Dermatologia. 2014;89(2):205-218. doi:10.1590/abd1806-4841.20142450.
13. Silatham Sermrittirong & Wim H.Van Brakel EnhancedStigma in leprosy: concepts, causes and determinants Lepr Rev (2014) 85, 36 – 47.
14. Annemieke Geluk, Kidist Bobosha, Jolien J. van der Ploeg-van Schip, John S. Spencer, Sayera Banu,x Marcia V. S. B. Martins, Sang-Nae Cho,‖ Kees L. M. C. Franken, Hee Jin Kim, Yonas Bekele,† Mohammad K. M. Uddin,x Sheikh Abdul Hadi,x Abraham Aseffa, Maria C. V. Pessolani, Geraldo M. B. Pereira, Hazel M. Dockrell, and Tom H. M. Ottenhoff A New Biomarkers with Relevance to Leprosy Diagnosis Applicable in Areas Hyperendemic for Leprosy J Immunol published online 13 April 2012 doi:10.4049/jimmunol.1103452
15. WHO Regional Office for South-East Asia. global strategy for further reducing the disease burden due to leprosy (Plan period: 2011–2015). 2009 [Internet]: [Cited 2013 July Availableat: http://www.searo.who.int/entity/global_leprosy_programme/documents/enhanced_global_strategy_2011_2015_operational_guidelines.pdf0)
16. Wim van Brakel Hugh Cross Etienne Declercq Sunil Deepak Diana Lockwood Paul Saunderson W Cairns SmithReview of Leprosy Research Evidence (2002 – 2009) and Implications for Current Policy and Practice Lepr Rev(2010) 81,228–275 e
17. Silatham Sermrittirong, Wim H. Van Brakel& J.F.G. Bunbers-aelen Raj Pracha Samasai Institute, Department of Disease Control, ThailandHow to reduce stigma in leprosy – a systematic literature review Lepr Rev (2014) 85, 149–157
18. Sunil Dogra, Tarun Narang & Bhushan KumarLeprosy - evolution of the path to eradication Indian J Med Res 137, January 2013, pp 15-35
19. De Souza M, Netto E, Nakatani M, Duthie M. 2014. Utility of recombinant proteins LID-1 and PADL in screening for M. leprae infection and leprosy. Trans R Soc Trop Med Hyg: accepted
20. Cardoso LP, Dias RF, Freitas AA, Hungria EM, Oliveira RM, Collovati M, Reed SG, Duthie MS, Stefani MM. 2013. Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology. BMC Infectious Diseases 13: 49
21. Foss NT, Callera F, Alberto FL. Anti-PGL1 levels in leprosy patients and their contacts.Braz J Med Biol Res. 1993;26(1):43-51.
22. Pönnighaus JM, Fine PE, Sterne JA, Wilson RJ, Msosa E, Gruer PJ, . Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992; 339:636 - 9;
23. http://dx.doi.org/10.1016/0140-6736(92)90794-4; PMID: 1347338 12.
24. Duthie MS, Balagon MF, Maghanoy A, Orcullo FM, Cang M, Dias RF, Collovati M, Reed SG, Land GA. 2014. Rapid Quantitative Serological Test for Detection of Infection with Mycobacterium leprae, the Causative Agent of Leprosy. J Clin Microbiol 52: 613-9
25. Duthie MS, Goto W, Ireton GC, Reece ST, Sampaio LH, Grassi AB, . Antigen-specific T-cell responses of leprosy patients. Clin Vaccine Immunol 2008; 15:1659 - 65 http://dx.doi.org/10.1128/CVI.00234-08; PMID: 18784342
26. Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, . Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis 2011; 11:26; http://dx.doi.org/10.1186/1471-2334-11-26; PMID: 21269435
DOI: http://dx.doi.org/10.18535/jmscr/v3i9.53
